FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Voyager Therapeutics (NASDAQ: VYGR) reported Q3 EPS of $. Revenue for the quarter came in at $60.4 million versus the consensus estimate of $6.38 million.
Voyager reported another record quarter, with momentum continuing in the fiscal fourth quarter to date.
Total revenue in the fiscal 2021 third quarter increased to US$60.4 million, up over 16x from US$3.6 million in the fiscal 2021 second quarter.Operating profit of US$30 million for the fiscal third quarter, with an operating margin of 50% - the Company's first ever quarter of operating profit.The... More
